We bring ideas to 
life ̶     for a better
health worldwide.


[¹⁸F]FET precursor

[18F]FET is a radiolabelled amino acid that is used as PET radiopharmaceutical in neuro-oncology. It has been demonstrated to be useful in the differential diagnosis between brain tumours and non-neoplastic lesions and between low-grade and high-grade gliomas. Although amino acid PET is currently included in U.S. and European guidelines for the imaging of gliomas, no approved PET tracer for brain cancer imaging is available. The FDA recently granted fast track designation for glioma imaging using [18F]FET.

 Find the product in research grade and GMP quality here and send us your quote request: 

Why choose ABX? 

ABX advanced biochemical compounds is a global frontrunner in radiopharmaceuticals, with a focus on positron emission tomography (PET) tracers. We develop and produce all compounds and components for any kind of radiotracer – from PET and SPECT precursors, PET reagent kits and cassettes, to complete radiopharmaceutical drug production in GMP environment.

Based in Radeberg, Germany, and founded in 1997, our team of more than 400 employees is specialised in custom synthesis and manufacturing of precursors and peptides according to GMP for active pharmaceutical ingredients. Thanks to our expertise combined with bleeding edge equipment, we reach highest research, production, and quality standards.

ABX is the only service provider of radiopharmaceutical production with a complete and independent supply chain – from precursor or peptide to excipients and sterile disposables. 

Meet us at

7th Theranostics World Congress

MARCH 22-24, 2024

Santiago, Chile

SNMMI 2024 Annual Meeting 

JUNE 8-11, 2024

Toronto, ON, Canada

37th Annual Congress EANM

OCTOBER 19-23, 2024

Hamburg, Germany